Pheenom when you said this back in 2009 "When SRX gets full Nasdaq listing in USA there will be shares open to 25 million US investors. Biotechs in USA that have growth rates of 75-100% trade at PE ratios of at least 35-40. AT a P.E of 35xeps of 35 cents this year this is sp of $12.25. A PE of 35x next years eps estimate of $69 cents = $24.15 a share. At present sp of $4.20 this is the most undervalued biotech I have ever seen and gap will be filled shortly with new highs. See my earlier prediction. This is my opinion only and do your own work as I have . I have been in industry over 30 yrs."
Mate with your level of expertise and what you know now about what Sirtex has achieved, where to now with this company in relation to growing the business and wealth for its shareholders?
nasdaq listing in the usa of srx, page-12
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.5¢ | $132.6K | 758.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 449688 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 955405 | 27 |
View Market Depth
| Last trade - 15.47pm 30/08/2024 (20 minute delay) ? |
| SRX (ASX) Chart |